Suggestions for evaluating and using hepatitis C screening tests;Propositions pour une stratégie d'évaluation et d'utilisation des tests de dépistage de l'hépatite C

Transfusion Clinique et Biologique

Volumn 3, Issue 5, 1996, Pages 279-288

  Lunel, F ^a   Rosenheim, M ^b   Duneton, Ph ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Evaluation; HCV; Methodology; Sensitivity; Serology; Specificity

Indexed keywords

BLOOD BANK; EVALUATION; HEPATITIS C; HUMAN; MASS SCREENING; METHODOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY;

BLOOD BANKS; EVALUATION STUDIES; HEPATITIS C; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0005531309     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1246-7820(96)80018-8     Document Type: Review

References (23)

1. Dubois F., Desenclos J.C., Mariotte N., Goudeau A. (1996) Séroprévalence de l'infection par le virus de l'hépatite C dans un échantillon national d'assurés sociaux volontaires à un examen de santé de la Sécurité Sociale. BEH, 17-19.
2. Couturier E., Brossard Y., Rotily M., Obadia Y., Rey D., Larsen M., Gillot R., Brunet J.B. (1996) Séroprévalence des anti-corps anti-VHC dans un échantillon exhaustif de femmes ayant terminé une grossesse en régions Ile-de-France-Alpes-Côtes d'Azur. BEH, 19-20.
3. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244, 359-362.
4. Kuo G., Choo Q.L., Alter H.J., Gitnik G.L., Redeker A.G., Purcell R.H., Miyamura T., Alter M.J., Stevens C.E., Tegmeier G.E., Bonino F., Colombo M., Lee W.S., Kuo C., Berger K., Shuster J.R., Overby L.R., Bradley D.W., Houghton M. (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science, 244, 362-364.
5. Donahue J.G., Munoz A., Ness P.M., Brown D.E., Yawn D.H., Mc Allister H.A., Reitz B.A., Nelson K.E. (1992) The declining risk of post-transfusion hepatitis C virus infection. N. Engl. J. Med., 327, 369-373.
6. Petersen L.R., Satten R., Dood M., Bush M., Kleinmann S., Grindon A., Lenes B., and the HIV sereconversion group (1994) Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion, 34, 283-289.
7. Zuck T.F. (1988) Transfusion-transmitted AIDS reassessed (editorial). N. Engl. J. Med., 318, 511-512.
8. Zuck T.F. (1989) How should we test the tests? Transfusion, 29, 3-4.
9. Ward J.W., Holmberg S.D., Allen J.R., Cohn D.L., Critchley S.E., Kleinmann S.H., Lenes B.A., Ravenholt O., Davis J.R., Quinn M.G., Jaffe H.W. (1988) Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N. Engl. J. Med., 318, 473-478.
10. Leon P., Lopez J.A., Domingo C., Echevarria J.M. (1993) Evaluation of laboratory assays for screening antibody to hepatitis C virus. Transfusion, 33, 268-270.
11. Vrielink H., Van der Poel C.L., Reesink H.W., Zaajer H.L., Lelie P.N. (1995) Transmission of hepatitis C by anti-HCV negative blood transfusion. Vox Sang., 68, 55-56.
12. Damen, Vrielink H., Lelie P.N., Zaaijer H.L., Reesink H.W. (1995) Incorrect Diagnosis of Hepatitis C with RIBA-3. Vox Sang., 69, 358.
13. Sloand E.M., Pitt E., Klein H. (1995) Safety of the Blood Supply. JAMA, 274, 1368-1372.
14. French study group for the standardization of Hepatitis C virus PCR (1994) Improvement of Hepatitis C virus RNA polymerase chain reaction through a multicentre quality control study. J. Virol. Methods, 49, 79-88.
15. e édition. Blackwell Scientific Publications Oxford.
16. Lunel F., Frangeul L., Perrin M., Huraux J.M. (1996) Diagnosis of acute HCV infection in immunosuppressed patients. IX Triennal symposium on viral hepatitis and liver disease abstract volume Roma, C102, 230 (Abstract).
17. Lunel F., Fretz C., Perrin M., Cresta P., Boudifa A.O., Fournel J.J., Huraux J.M. (1996) Prospective study of the discordances between two different ELISA for the detection of anti-HCV antibodies. IX Triennal Symposium on Viral Hepatitis and Liver Disease abstract volume, Roma, C 180, 249 (Abstract).
18. Bjoro K., Froland S.S., Yun Z., Samdal H.H., Haaland T. (1994) Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N. Engl. J. Med., 331, 1607-1611.
19. Bukh J., Wantzin P., Krogsgaard K., Knudsen F., Purcell R.H., Miller R.H. (1993) High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Dialysis HCV Study Group. J. Infect. Dis., 168, 1343-1348.
20. Lok A.S.F., Chien D., Choo Q.L., Chan T.M., Chiu K.W., Cheng I.K.P., Houghton M., Kuo G. (1993) Antibody response to core, envelope and nonstructural hepatitis C virus antigens: Comparison of immunocompetent and immunosuppressed patients. Hepatology, 18, 3, 497, 502.
21. Grenier B. (1989) La Décision Médicale, Masson, Paris.
22. e édition. John Wiley & Sons, New York.
23. Thorn R.M., Braman V., Stella M., Yi A. (1989) Assessment of HIV-1 screening test sensitivities using serially diluted positive sera can give misleading results. Transfusion, 29, 78-80.